alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 121 (Thursday, June 25, 2009)]
[Notices]
[Page 30290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14936]



[[Page 30290]]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. OR09-5-000]


Enbridge Energy, Limited Partnership; Notice of Supplement to 
Facilities Surcharge Settlement

June 18, 2009.
    Take notice that on February 27, 2009, Enbridge Energy, Limited 
Partnership (Enbridge Energy), with the support of the Canadian 
Association of Petroleum Producers, submitted a Supplement to the 
Facilities Surcharge Settlement (Supplemental Settlement) approved by 
the Commission on June 30, 2004, in Docket No. OR04-2-000. Enbridge 
Energy, Limited Partnership, 107 FERC ] 61,336 (2004).
    Initial comments on the Supplemental Settlement should be filed on 
or before June 29, 2009. Reply comments should be filed on or before 
July 6, 2009.

Kimberly D. Bose,
Secretary.
 [FR Doc. E9-14936 Filed 6-24-09; 8:45 am]
BILLING CODE 6717-01-P
[Federal Register Volume 74, Number 109 (Tuesday, June 9, 2009)]
[Notices]
[Page 27340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13527]


-----------------------------------------------------------------------

DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT

[Docket No. FR-5300-N-06A]


Notice of Availability: Notice of Funding Availability (NOFA) for 
Fiscal Year (FY) 2009 Lead-Based Paint Hazard Control Grant Program and 
Lead Hazard Reduction Demonstration Grant Program; Technical Correction

AGENCY: Office of Healthy Homes and Lead Hazard Control, HUD.

ACTION: Notice of technical correction.

-----------------------------------------------------------------------

SUMMARY: On May 22, 2009, HUD posted on its Web site its Notice of 
Funding Availability (NOFA) for HUD's FY2009 Lead-Based Paint Hazard 
Control Grant Program and Lead Hazard Reduction Demonstration Grant 
Program. Today's Federal Register publication announces that HUD has 
posted on its Web site a revised NOFA that corrects Appendix A of the 
NOFA and extends the deadline for submitting waiver requests to reduce 
the statutory match. Specifically, HUD inadvertently omitted a number 
of jurisdictions that are eligible for the FY2009 Lead Hazard Reduction 
Demonstration Grant Program from part A of Appendix A, entitled 
``Cities, Towns, Counties, and States Having at Least One Place or 
County with 3,500 or More Occupied Rental Housing Units Built Before 
1940, and Eligible States and Tribes.'' The revised Appendix A is 
available at http://www.hud.gov/offices/lead/09NOFA/leadcombo.cfm. In 
addition, in order to provide equal opportunity to all eligible 
applicants, the deadline for submitting waiver requests to reduce the 
statutory match amount from 25% to 10% is being extended from June 10, 
2009 to June 23, 2009. The period for HUD to review the requests is 
extended from June 22, 2009 to June 30, 2009. The deadline for receipt 
of the applications in HUD headquarters remains 5:00 PM eastern time 
July 20, 2009.

FOR FURTHER INFORMATION CONTACT: For information concerning the Lead-
Based Paint Hazard Control Grant Program and Lead Hazard Reduction 
Demonstration Grant Program, contact Warren Friedman, Senior Advisor to 
the Director, Office of Healthy Homes and Lead Hazard Control, 
Department of Housing and Urban Development, 451 Seventh Street, SW., 
Room 8236, Washington, DC 20410-3000; telephone number 202-402-7574 
(this is not a toll-free number). Persons with speech or hearing 
impairments may access this telephone number via TTY by calling the 
toll-free Federal Information Relay Service during working hours at 
800- 877-8339.

    Dated: June 3, 2009.
Jon L. Gant,
Director, Office of Healthy Homes and Lead Hazard Control.
[FR Doc. E9-13527 Filed 6-5-09; 11:15 am]
BILLING CODE 4210-67-P
* This matter is being decided by a quorum. 28 U.S.C. §

46(d).

** Pursuant to 5 TH C IR . R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 98-10633 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus LARRY ALLEN RESSLER, Defendant-Appellant.

- - - - - - - - - - Appeal from the United States District Court for the Northern District of Texas

USDC No. 5:96-CV-049

- - - - - - - - - - February 11, 1999 Before BARKSDALE and EMILIO M. GARZA, Circuit Judges. *
PER CURIAM: ** Larry Allen Ressler, federal prisoner # 22047-077, appeals from the district court’s dismissal of his second 28 U.S.C. § 2255 motion to vacate, set aside, or correct his sentence as abusive. Ressler argues that he exercised due diligence in obtaining and attempting to secure the information pertaining to the “housebreaking” convictions and that the district courtNo. 98-10633 -2- abused its discretion when it summarily dismissed his motion for abuse of the writ without first holding an evidentiary hearing. We have reviewed the record and find no reversible error. The district court did not abuse its discretion in dismissing Ressler’s second § 2255 motion as abusive without first holding an evidentiary hearing because Ressler failed to show cause for his procedural default and there would be no miscarriage of justice if the court did not to consider the claim. United States v. Flores , 981 F.2d 231, 234-36 (5th Cir. 1993). Accordingly, the judgment of the district court is AFFIRMED.
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002









In connection with the Quarterly Report of Sentry Petroleum Ltd. (the "Company") on Form 10-Q for the period ended May 31, 2010 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Raj Rajeswaran, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.











Dated this 7th day of July, 2010.







| |     |                                                           
| | --- | ----------------------------------------------------------
| |     |                                                           
| | BY: | RAJ RAJESWARANRaj Rajeswaran, 
Principal Executive Officer











---
3oo-if

COA# 08-12-00298-CR OFFENSE: 22.02

Robert Carver v. The State of __..__,, ^

STYLE: Texas COUNTY: Denton

COA DISPOSITION: AFFIRM TRIAL COURT: 362nd District Court

DATE: 1/28/15 Publish: NO TC CASE #: F-2010-1715-D

IN THE COURT OF CRIMINAL APPEALS

ELECTRONIC RECORD

Robert Carver v. The State of

STYLE: Texas

PftO SF Petition

FOR DISCRETIONARY REVIEW IN CCA IS:

d^fL

DATE: n.<?lf3/2-0/S'

JUDGE: VM U<^U^a^.

CCA#:

CCA Disposition:

DATE:

JUDGE:

SIGNED:

PUBLISH:

REHEARING IN CCA IS:

JUDGE: ____

PC:_

DNP:

MOTION FOR
#### Paul Marinaccio, Sr., Respondent, v Town of Clarence, Defendant, and Kieffer Enterprises, Inc., Appellant.

Submitted May 6, 2013;

decided June 25, 2013

Motion for reargument etc. denied *[see*20 NY3d 506 (2013)].

Judges Rivera and Abdus-Salaam taking no part.
# Clinical High Risk for Psychosis

NIMH held a technical assistance teleconference for potential applicants where NIMH staff answered questions related to the following funding opportunity announcements.

**RFA-MH-20-341, Clinical High Risk for Psychosis: Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed) ****

**RFA-MH-20-340, Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed)** **

The teleconference was held on Tuesday, December 17, 2019 at 3:00 pm EST. Please send inquiries to chrfoas@mail.nih.gov.

Read a summary of the teleconference (PDF).
# Attention Deficit Hyperactivity Disorder

> 
The National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH), is the nation's leading federal funder of research on ADHD. 

## What is attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder marked by trouble controlling impulsive behavior, difficulty paying attention, or overactivity. It is one of the most common neurodevelopmental disorders of childhood. ADHD interferes with a person's ability to stay on a task and maintain focus. The person may act without thinking or have difficulty with self-control. Some of the warning signs of ADHD in children include:

                    - Failure to listen to instructions and miss details
                    - Inability to organize oneself and schoolwork
                    - Trouble paying attention to and responding to details
                    - Restlessness

                    - Fidgeting with hands and feet
                    - Talking too much
                    - Leaving projects, chores, and homework unfinished

Some people with ADHD have symptoms related to hyperactivity/impulsiveness, while others may be mainly inattentive. Some people have a combination of both types of symptoms. There are several types of ADHD, which is usually diagnosed in childhood, although the condition can continue into the adult years.

The causes and risk factors or ADHD are unknown although genes and a combination of environmental factors may play a role. There is no cure for ADHD, but medicines can help decrease impulsivity and hyperactivity and increase attention. Other options include psychotherapy, education or training, or a combination of treatments.

file-medical

## How can I or my loved one improve care for people with attention deficit hyperactivity disorder?

Consider participating in a clinical trial so clinicians and scientists can learn more about ADHD and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease. 

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them. 

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with ADHD at Clinicaltrials.gov, a database of current and past clinical studies and research results. 
> Where can I find more information about attention deficit hyperactivity disorder?
The following organizations and resources can help individuals, families, friends, and caregivers of people living with ADHD: 

Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)Phone: 301-306-7070 or 866-200-8098

**Learning Disabilities Association of America**Phone: 412-341-1515

PubMed

book-open
<PAGE>

EXHIBIT 24.1



                                  POWER OF ATTORNEY
                                           

     KNOWN ALL MEN BY THESE PRESENTS that each individual whose signature
appears below constitutes and appoints Myles M. Kranzler and Edward J.
Klinsport, and each of them, his true and lawful attorneys-in-fact and agents
with full power of substitution, for him and in his name, place and stead in any
and all capacities, to sign the Annual Report on Form 10-K of Base Ten Systems,
Inc. for the fiscal year ended October 31, 1996 and any amendments thereto, and
to file same, with all exhibits thereto, and all documents in connection
therewith, with the Securities and Exchange Commission, pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934, as amended, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done to
comply with the provisions of the Securities Act of 1934, and all requirements
of the Securities and Exchange Commission, hereby ratifying and confirming all
that said attorneys-in-fact and agents or any of them, or their or his
substitutes, may lawfully do or cause to be done by virtue thereof. 


     
                                   /s/ Myles M. Kranzler    
                                   --------------------------
                                   Myles M. Kranzler
                              
                              
                                   /s/ Edward J. Klinsport  
                                   --------------------------
                                   Edward J. Klinsport
                              
                              
                                   /s/ Alan J. Eisenberg    
                                   --------------------------
                                   Alan J. Eisenberg
                              
                              
                                   /s/ Alexander M. Adelson 
                                   --------------------------
                                   Alexander M. Adelson
                              
                              
                                   /s/ Alan S. Poole   
                                   --------------------------
                                   Alan S. Poole
                              
                              
                                   /s/ Susan M. Klinsport   
                                   --------------------------
                                   Susan M. Klinsport
FIRST COURT OF APPEALS 

INFORMATION SHEET BY COURT REPORTERS 

You are expected to file the reporter’s record by the original due date. See Tex. R. App. P.35. If 

a reporter determines that the due date may not be met, please advise the Clerk of the Court of 

Appeals immediately in writing, stating the reason and the due date by which the record will be 

filed. Generally speaking, for good cause shown, the Court will grant no more than two 

extensions from the original record due date, each extension not to exceed 30 days in regular 

appeals and 10 days in accelerated appeals for a total period not to exceed 60 days in regular 

appeals and 20 days in accelerated appeals. 

 

Appellate Case Number: Trial Court Case Number: 

(1) Is there a Reporter's Record? Y N

(2) Are you the only court reporter involved in this appeal? Y N

If not, please provide the names and addresses of all other court

reporters below.

(3) Has the appellant requested that the reporter’s record be prepared or 

has the trial court ordered that the record be prepared?

 Y N

(4) Please select from the following options:

 A. The appellant has paid for the record.

 B. The appellant has made arrangements to pay for the record

 C. The appellant is appealing as indigent.

 D. The appellant has not paid or made arrangements to pay for the

 record and is not appealing as indigent.

(5) Extension (fill out if extension is required for any reason other than payment)

I was unable to file the record in this appeal by ________. I expect the record 

in this appeal to be approximately _______ pages. The record covers 

_______days of testimony. I believe that I can file the record by _________. I 

ask that the court grant an extension until that time for filing the record.

Additional Comments: ___________________________________________

Court Reporter's Signature, Full Address, Email Address and Telephone Number:

_______________________________________________________________________ 

_______________________________________________________________________

 FILED IN 1st COURT OF APPEALS HOUSTON, TEXAS 7/13/2015 1:13:49 PM CHRISTOPHER A. PRINE Clerk
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 363 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
H. RES. 363

   Recognizing the roles and contributions of America's teachers to 
building and enhancing the Nation's civic, cultural, and economic well-
                                 being.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 9, 2019

  Mr. Graves of Missouri (for himself, Mr. Loebsack, Mr. Thompson of 
    California, Mr. McGovern, Mr. Bost, Mr. Guthrie, Mr. Emmer, Ms. 
 DelBene, Mr. Luetkemeyer, Mr. Fitzpatrick, Ms. Davids of Kansas, and 
 Mrs. Hartzler) submitted the following resolution; which was referred 
                to the Committee on Education and Labor

_______________________________________________________________________

                               RESOLUTION

 
   Recognizing the roles and contributions of America's teachers to 
building and enhancing the Nation's civic, cultural, and economic well-
                                 being.

Whereas education and knowledge are the foundation of America's current and 
        future strength;
Whereas the purpose of National Teacher Appreciation Week, held during May 6, 
        2019, through May 10, 2019, is to raise public awareness of the 
        unquantifiable contributions of teachers and to promote greater respect 
        and understanding for the teaching profession; and
Whereas students, schools, communities, and a number of organizations 
        representing educators are hosting teacher appreciation events in 
        recognition of National Teacher Appreciation Week: Now, therefore, be it
    Resolved, That the House of Representatives thanks and promotes the 
profession of teaching by encouraging students, parents, school 
administrators, and public officials to participate in teacher 
appreciation events during National Teacher Appreciation Week.
                                 <all>
```
[Federal Register Volume 74, Number 118 (Monday, June 22, 2009)]
[Notices]
[Page 29498]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14515]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Environmental Health Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Environmental Health 
Sciences Special Emphasis Panel; Environmental Sensors for Personal 
Exposure Assessment.
    Date: July 9, 2009.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Southpoint, Hilton Garden Inn Durham 
Southpoint, 7007 Fayetteville Road, Durham, NC 27713.
    Contact Person: RoseAnne M McGee, Associate Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research 
and Training, Nat. Institute of Environmental Health Sciences, P.O. 
Box 12233, MD EC-30, Research Triangle Park, NC 27709, (919) 541-
0752, <a href="/cdn-cgi/l/email-protection#9bf6f8fcfefeaadbf5f2fef3e8b5f5f2f3b5fcf4ed"><span class="__cf_email__" data-cfemail="2e434d494b4b1f6e40474b465d0040474600494158">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.115, 
Biometry and Risk Estimation--Health Risks from Environmental 
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety 
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic 
Research and Education; 93.894, Resources and Manpower Development 
in the Environmental Health Sciences; 93.113, Biological Response to 
Environmental Health Hazards; 93.114, Applied Toxicological Research 
and Testing, National Institutes of Health, HHS)

    Dated: June 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-14515 Filed 6-19-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Parviz Noghrey, Respondent-Appellant, v Town of Brookhaven et al., Appellants-Respondents.

Submitted June 25, 2012;

decided September 18, 2012

On the Court’s own motion, appeal by Town of Brookhaven et al. and appeal by Parviz Noghrey dismissed, without costs, upon the ground that the order and judgment appealed from does not finally determine the action within the meaning of the Constitution. Forms of relief within a single cause of action cannot be expressly or impliedly severed *(see Burke v Crosson,*85 NY2d 10, 18 n 5 [1995]). The unresolved items of relief render the order and judgment nonfinal. Motion to modify statutory stay denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT JUNE 30, 1998, AND THE STATEMENTS OF OPERATIONS FOR THE SIX MONTHS
ENDED JUNE 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         655,000
<SECURITIES>                                         0
<RECEIVABLES>                                   71,000
<ALLOWANCES>                                     6,400
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       8,323,200
<DEPRECIATION>                               5,133,100
<TOTAL-ASSETS>                               5,033,900
<CURRENT-LIABILITIES>                          850,000
<BONDS>                                      2,050,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 5,033,900
<SALES>                                              0
<TOTAL-REVENUES>                             1,840,400
<CGS>                                                0
<TOTAL-COSTS>                                1,495,900
<OTHER-EXPENSES>                              (18,600)
<LOSS-PROVISION>                                19,900
<INTEREST-EXPENSE>                             120,800
<INCOME-PRETAX>                                242,300
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            242,300
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   242,300
<EPS-PRIMARY>                                     3.01
<EPS-DILUTED>                                        0
        

</TABLE>